Cunjing Yu

568 total citations
8 papers, 178 citations indexed

About

Cunjing Yu is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Cunjing Yu has authored 8 papers receiving a total of 178 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Cunjing Yu's work include Dermatology and Skin Diseases (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Cancer Cells and Metastasis (1 paper). Cunjing Yu is often cited by papers focused on Dermatology and Skin Diseases (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Cancer Cells and Metastasis (1 paper). Cunjing Yu collaborates with scholars based in China, United States and United Kingdom. Cunjing Yu's co-authors include Yuan Fang, Ning Li, Yizhou Zhao, Huaqing Liu, Shuhang Wang, Sarah Howie, Richard Weller, Chengcan Yao, Siobhan Crittenden and Jennifer M. Felton and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Allergy and Clinical Immunology.

In The Last Decade

Cunjing Yu

7 papers receiving 174 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cunjing Yu China 5 77 56 42 34 33 8 178
André C. Mueller Austria 6 105 1.4× 47 0.8× 10 0.2× 65 1.9× 10 0.3× 9 209
Željko Mijušković Serbia 7 57 0.7× 56 1.0× 29 0.7× 46 1.4× 4 0.1× 27 155
Martina Merli Italy 7 52 0.7× 94 1.7× 59 1.4× 79 2.3× 11 0.3× 24 176
Md Maksudul Alam United States 8 211 2.7× 41 0.7× 5 0.1× 18 0.5× 27 0.8× 14 293
Rosemarie Sellati United States 5 45 0.6× 41 0.7× 13 0.3× 99 2.9× 4 0.1× 5 198
Sami Yokoo Brazil 9 191 2.5× 42 0.8× 3 0.1× 16 0.5× 10 0.3× 15 260
Gianluca Quintini Germany 8 76 1.0× 25 0.4× 7 0.2× 41 1.2× 14 0.4× 9 148
L. Tiffany Reed United States 5 136 1.8× 122 2.2× 4 0.1× 26 0.8× 48 1.5× 6 284
Coralie Dorard Austria 7 127 1.6× 41 0.7× 7 0.2× 11 0.3× 8 0.2× 8 170

Countries citing papers authored by Cunjing Yu

Since Specialization
Citations

This map shows the geographic impact of Cunjing Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cunjing Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cunjing Yu more than expected).

Fields of papers citing papers by Cunjing Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cunjing Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cunjing Yu. The network helps show where Cunjing Yu may publish in the future.

Co-authorship network of co-authors of Cunjing Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Cunjing Yu. A scholar is included among the top collaborators of Cunjing Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cunjing Yu. Cunjing Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Yu, Cunjing, et al.. (2025). Identification of biomarkers and immune microenvironment associated with heart failure through bioinformatics and machine learning. Frontiers in Molecular Biosciences. 12. 1580880–1580880.
2.
Deva, Sanjeev, Caicun Zhou, Peter K. H. Lau, et al.. (2024). A first-in-human phase 1a dose-escalation study of BGB-15025 (HPK1 inhibitor) as monotherapy and in combination with tislelizumab (TIS; anti-PD-1 antibody) in patients (pts) with advanced solid tumors.. Journal of Clinical Oncology. 42(16_suppl). 2585–2585. 4 indexed citations
3.
Fang, Yuan, Shuhang Wang, Yizhou Zhao, et al.. (2023). Targeted protein degrader development for cancer: advances, challenges, and opportunities. Trends in Pharmacological Sciences. 44(5). 303–317. 60 indexed citations
4.
Hou, Ming‐Mo, Kun‐Ming Rau, Yoon‐Koo Kang, et al.. (2020). 77 Association between programmed death-ligand 1 (PD-L1) expression and gene signatures of response or resistance to tislelizumab monotherapy in hepatocellular carcinoma (HCC). SHILAP Revista de lepidopterología. A47.2–A48. 4 indexed citations
5.
Robb, Calum T., Henry J. McSorley, Tomohiro Aoki, et al.. (2017). Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis. Journal of Allergy and Clinical Immunology. 141(1). 152–162. 51 indexed citations
6.
Leitch, E. Carol McWilliam, Cunjing Yu, Zoe C Venables, et al.. (2016). Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. Journal of Allergy and Clinical Immunology. 138(2). 482–490.e7. 29 indexed citations
7.
8.
Yang, Chenglin, Jen-Fu Shih, Tzu‐Chieh Chao, et al.. (2008). Use of BIBW 2992, a novel irreversible EGFR/HER2 TKI, to induce regression in patients with adenocarcinoma of the lung and activating EGFR mutations: Preliminary results of a single-arm phase II clinical trial. Journal of Clinical Oncology. 26(15_suppl). 8026–8026. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by André C. Mueller Breakdown of academic impact, for papers by Željko Mijušković Breakdown of academic impact, for papers by Martina Merli Breakdown of academic impact, for papers by Md Maksudul Alam Breakdown of academic impact, for papers by Rosemarie Sellati Breakdown of academic impact, for papers by Sami Yokoo Breakdown of academic impact, for papers by Gianluca Quintini Breakdown of academic impact, for papers by L. Tiffany Reed Breakdown of academic impact, for papers by Coralie Dorard
Rankless by CCL
2026